gypenoside-LXXV has been researched along with Diabetes-Mellitus--Type-2* in 1 studies
1 other study(ies) available for gypenoside-LXXV and Diabetes-Mellitus--Type-2
Article | Year |
---|---|
A novel natural PPARĪ³ agonist, Gypenoside LXXV, ameliorates cognitive deficits by enhancing brain glucose uptake via the activation of Akt/GLUT4 signaling in db/db mice.
Topics: Animals; Brain; Cognition; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Glucose; Glucose Transporter Type 4; Gynostemma; Insulin; Insulin Resistance; Mice; PPAR gamma; Proto-Oncogene Proteins c-akt; Saponins; Triterpenes | 2022 |